StockData
Inhibrx Biosciences, Inc. logo

Inhibrx Biosciences, Inc. (INBX) KPIs and segments

INBXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$77.66−5.64 (-6.77%)

Close on Nov 16, 2026Market cap $1.14BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Inhibrx Biosciences's business

Coming soon

This tab will track the numbers specific to Inhibrx Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?